New Value invests directly in private, upwardly mobile companies located in Switzerland.
|2010-09-08||Sensimed||Series B - II||$8.5M||Agate Medical Investments|
|Idiag||Other Investors||BioMedCredit, BioMedPartners, and EPS Value Plus|
|Swiss Medical Solution||Other Investors||Adamant Biomedical Investments, and EPS Value Plus|
|Solar Plant Swiss||Other Investors||EPS Value Plus, and Glarner Kantonalbank|
|Silentsoft||Other Investors||EPS Value Plus, and VI Partners|